Zobrazeno 1 - 10 of 33 pro vyhledávání: '"Nobuto Okamoto"'
1
Possibility of Neoadjuvant Treatment for Radiologically Judged Resectable Pancreatic Cancer
Autor: Takehiro Okabayashi, Kenta Sui, Motoyasu Tabuchi, Takahiro Murokawa, Shinichi Sakamoto, Jun Iwata, Sojiro Morita, Nobuto Okamoto, Tatsuo Iiyama, Yasuhiro Shimada, Toshiyoshi Fujiwara
Publikováno v: Journal of Clinical Medicine; Volume 11; Issue 22; Pages: 6792
Survival remains poor even after resection of pancreatic cancer and the postoperative recurrence rate is extremely high. Thus, neoadjuvant treatment may improve outcomes for resectable pancreatic cancer (RPC). This study evaluated the efficacy of neo
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac1fada2bc606b65b73d3064d09bc2c4
https://doi.org/10.3390/jcm11226792
Zobrazit plný text záznamu
2
Akademický článek
Glycemic variability is an independent predictive factor for development of hepatic fibrosis in nonalcoholic fatty liver disease.
Autor: Motoi Hashiba, Masafumi Ono, Hideyuki Hyogo, Yukio Ikeda, Kosei Masuda, Reiko Yoshioka, Yoichi Ishikawa, Yuri Nagata, Kensuke Munekage, Tsunehiro Ochi, Akira Hirose, Yasuko Nozaki-Fujimura, Shuhei Noguchi, Nobuto Okamoto, Kazuaki Chayama, Narufumi Suganuma, Toshiji Saibara
Publikováno v: PLoS ONE, Vol 8, Iss 11, p e76161 (2013)
UNLABELLED:Patients with nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) often have metabolic disorders including insulin resistance and type 2 diabetes mellitus (T2DM). We clarified the predictive factors in glucose
Externí odkaz: https://doaj.org/article/8c40f81012c140ecafc470e4582acc5a
Zobrazit plný text záznamu
3
Evaluation of postprandial hypoglycemia in patients with nonalcoholic fatty liver disease by oral glucose tolerance testing and continuous glucose monitoring
Autor: Tsunehiro Ochi, Yasuko Nozaki, Kensuke Munekage, Yusuke Oki, Hideyuki Hyogo, Akira Hirose, Masafumi Ono, Kosei Masuda, Nobuto Okamoto, Hiroshi Mizuta, Toshiji Saibara
Publikováno v: European Journal of Gastroenterology & Hepatology. 30:797-805
Nonalcoholic fatty liver disease (NAFLD) is often associated with insulin resistance and glucose intolerance. Postprandial hypoglycemia frequently occurs in NAFLD patients; however, the details remain unclear.The 75-g oral glucose tolerance test (75g
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d7077329f064894a0719c42a5b5cee14
https://doi.org/10.1097/meg.0000000000001118
Zobrazit plný text záznamu
4
High fasting insulin concentrations may be a pivotal predictor for the severity of hepatic fibrosis beyond the glycemic status in non-alcoholic fatty liver disease patients before development of diabetes mellitus
Autor: Tsunehiro Ochi, Narufumi Suganuma, Nobuto Okamoto, Masafumi Ono, Toshiji Saibara, Shuhei Noguchi, Kosei Masuda, Kensuke Munekage
Publikováno v: Hepatology Research. 47:983-990
Background Insulin resistance and type 2 diabetes mellitus (T2DM) contribute to the progression of nonalcoholic fatty liver disease (NAFLD). However, the relationship between glucose metabolic factors and the histological severity in NAFLD patients b
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::324ce6682a2a468c9d0e08781676a5e1
https://doi.org/10.1111/hepr.12832
Zobrazit plný text záznamu
5
Patatin-like phospholipase domain-containing protein 3 is involved in hepatic fatty acid and triglyceride metabolism through X-box binding protein 1 and modulation of endoplasmic reticulum stress in mice
Autor: Tsunehiro Ochi, Shuji Sakamoto, Nobuto Okamoto, Masafumi Ono, Masayuki Tsuda, Yoshihiro Hayashi, Kensuke Munekage, Takuma Higuchi, Katsumi Toda, Jude A. Oben, Toshiji Saibara
Publikováno v: Hepatology Research. 46:584-592
AIM: Nonalcoholic steatohepatitis (NASH) is the major cause of chronic liver disease worldwide. Endoplasmic reticulum (ER) stress is considered to be an important pathological characteristic in NASH. A sequence variation (I148M) in the patatin-like p
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::095b875c144d86455c6fc4260304ddb0
https://doi.org/10.1111/hepr.12587
Zobrazit plný text záznamu
6
Differences in characteristics of glucose intolerance between patients with NAFLD and chronic hepatitis C as determined by CGMS
Autor: Toshiji Saibara, Tsunehiro Ochi, Masafumi Ono, Takumi Kawaguchi, Masahiro Yamaguchi, Akira Hiramatsu, Takuji Torimura, Akira Hirose, Hiroshi Mizuta, Kosei Masuda, Shuhei Noguchi, Narufumi Suganuma, Takashi Nakahara, Kensuke Munekage, Kazuaki Chayama, Yuichi Koshiyama, Nobuto Okamoto, Mitsunari Ogasawara, Eisuke Murakami
Publikováno v: Scientific Reports, Vol 7, Iss 1, Pp 1-9 (2017)
Scientific Reports
Glucose intolerance frequently develops in accordance with the progression of chronic liver disease. However, differences in the characteristics of glucose intolerance between patients with nonalcoholic fatty liver disease (NAFLD) and those with chro
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::584bc656aefac5a0954a5c240373675a
https://doi.org/10.1038/s41598-017-09256-4
Zobrazit plný text záznamu
7
High fasting insulin concentrations may be a pivotal predictor for the severity of hepatic fibrosis beyond the glycemic status in non-alcoholic fatty liver disease patients before development of diabetes mellitus
Autor: Kosei, Masuda, Shuhei, Noguchi, Masafumi, Ono, Tsunehiro, Ochi, Kensuke, Munekage, Nobuto, Okamoto, Narufumi, Suganuma, Toshiji, Saibara
Publikováno v: Hepatology research : the official journal of the Japan Society of Hepatology. 47(10)
Insulin resistance and type 2 diabetes mellitus (T2DM) contribute to the progression of non-alcoholic fatty liver disease (NAFLD). However, the relationship between glucose metabolic factors and the histological severity in NAFLD patients before deve
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::373e06618950dd913fbef63390b96c80
https://pubmed.ncbi.nlm.nih.gov/27794176
Zobrazit plný text záznamu
8
Usefulness of Technetium-99 m-2-methoxy-isobutyl-isonitrile liver scintigraphy for evaluating disease activity of non-alcoholic fatty liver disease
Autor: Naoki Akagi, Masafumi Ono, Yasuhiro Ogawa, Toshiji Saibara, Akira Hirose, Kensuke Munekage, Nobuto Okamoto, Mitsutaka Fukumoto, Tsunehiro Ochi, Kosei Masuda
Publikováno v: Hepatology Research. 42:273-279
Aim: Non-alcoholic steatohepatitis (NASH) is a progressive form of non-alcoholic fatty liver disease (NAFLD). Therefore, it is important to evaluate disease activity and distinguish NASH from simple steatosis in NAFLD. Technetium-99 m-2-methoxy-isobu
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::bdd174ea15c467a37cfdb0a9ff342ccb
https://doi.org/10.1111/j.1872-034x.2011.00923.x
Zobrazit plný text záznamu
9
Angiotensinogen gene haplotype is associated with the prevalence of Japanese non-alcoholic steatohepatitis
Autor: Masaya Takahashi, Mitsunari Ogasawara, Toshiji Saibara, Masafumi Ono, Yasuko Nozaki, Kensuke Munekage, Tsunehiro Ochi, Akira Hirose, Nobuto Okamoto
Publikováno v: Hepatology Research. 41:1223-1229
Aim Non-alcoholic steatohepatitis (NASH) patients frequently have hypertension, which is considered to be an important predictive factor for the subsequent development of hepatic fibrosis. The renin-angiotensin system is also known to contribute to t
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::e32e9b8e1a1a16e5322b5ce5b4bb5069
https://doi.org/10.1111/j.1872-034x.2011.00883.x
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje